Prot #MM-121-01-02-09: A Phase 2 Study of MM-121 in Combination with Docetaxel or Pemetrexed versus Docetaxel or Pemetrexed Alone in Patients with Heregulin Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Project: Research project

Project Details

StatusFinished
Effective start/end date5/22/15 → 5/22/21

Funding

  • Clintrax Global, Inc. (Prot #MM-121-01-02-09 // Prot #MM-121-01-02-09)
  • Merrimack Pharmaceuticals, Inc (Prot #MM-121-01-02-09 // Prot #MM-121-01-02-09)